Resmeta 100mg Tabs 14s
Rs. 2,550.00
In stock
SKU
372397
Product Overview
Resmetirom is a partial agonist of the thyroid hormone receptor-beta (THR-β). Resmetirom produced 83.8% of the maximum response compared to triiodothyronine (T3), with an EC50 of 0.21 µM in an in vitro functional assay for THR-β activation. The same functional assay for thyroid hormone receptor-alpha (THR-α) agonism showed 48.6% efficacy for Resmetirom relative to T3, with an EC50 of 3.74 µM. THR-β is the major form of THR in the liver, and stimulation of THR-β in the liver reduces intrahepatic triglycerides, whereas actions of thyroid hormone outside the liver, including in heart and bone, are largely mediated through THR-α.
Indication
Resmetirom is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) .
Directions for Use
1. Take one tablet orally with a full glass of water.
2. Follow the dosage instructions provided by your healthcare provider.
3. Do not crush or chew the tablet.
4. Store the medication at room temperature away from moisture and heat.
Precautions
- Consult with a healthcare professional before starting this medication.
- Inform your doctor of any allergies or medical conditions before use.
- Do not exceed the recommended dosage to avoid potential side effects.
- Keep out of reach of children.
Storage Instructions
Store Resmeta 100mg Tabs 14s in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture and heat.
Manufacturer Information
Helix is a reputable pharmaceutical company known for producing high-quality medications to improve health and well-being. With a commitment to excellence and innovation, Helix continues to develop safe and effective products for consumers worldwide.
Resmetirom is a partial agonist of the thyroid hormone receptor-beta (THR-β). Resmetirom produced 83.8% of the maximum response compared to triiodothyronine (T3), with an EC50 of 0.21 µM in an in vitro functional assay for THR-β activation. The same functional assay for thyroid hormone receptor-alpha (THR-α) agonism showed 48.6% efficacy for Resmetirom relative to T3, with an EC50 of 3.74 µM. THR-β is the major form of THR in the liver, and stimulation of THR-β in the liver reduces intrahepatic triglycerides, whereas actions of thyroid hormone outside the liver, including in heart and bone, are largely mediated through THR-α.
Indication
Resmetirom is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) .
Directions for Use
1. Take one tablet orally with a full glass of water.
2. Follow the dosage instructions provided by your healthcare provider.
3. Do not crush or chew the tablet.
4. Store the medication at room temperature away from moisture and heat.
Precautions
- Consult with a healthcare professional before starting this medication.
- Inform your doctor of any allergies or medical conditions before use.
- Do not exceed the recommended dosage to avoid potential side effects.
- Keep out of reach of children.
Storage Instructions
Store Resmeta 100mg Tabs 14s in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture and heat.
Manufacturer Information
Helix is a reputable pharmaceutical company known for producing high-quality medications to improve health and well-being. With a commitment to excellence and innovation, Helix continues to develop safe and effective products for consumers worldwide.
Product Overview
Resmetirom is a partial agonist of the thyroid hormone receptor-beta (THR-β). Resmetirom produced 83.8% of the maximum response compared to triiodothyronine (T3), with an EC50 of 0.21 µM in an in vitro functional assay for THR-β activation. The same functional assay for thyroid hormone receptor-alpha (THR-α) agonism showed 48.6% efficacy for Resmetirom relative to T3, with an EC50 of 3.74 µM. THR-β is the major form of THR in the liver, and stimulation of THR-β in the liver reduces intrahepatic triglycerides, whereas actions of thyroid hormone outside the liver, including in heart and bone, are largely mediated through THR-α.
Indication
Resmetirom is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) .
Directions for Use
1. Take one tablet orally with a full glass of water.
2. Follow the dosage instructions provided by your healthcare provider.
3. Do not crush or chew the tablet.
4. Store the medication at room temperature away from moisture and heat.
Precautions
- Consult with a healthcare professional before starting this medication.
- Inform your doctor of any allergies or medical conditions before use.
- Do not exceed the recommended dosage to avoid potential side effects.
- Keep out of reach of children.
Storage Instructions
Store Resmeta 100mg Tabs 14s in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture and heat.
Manufacturer Information
Helix is a reputable pharmaceutical company known for producing high-quality medications to improve health and well-being. With a commitment to excellence and innovation, Helix continues to develop safe and effective products for consumers worldwide.
Resmetirom is a partial agonist of the thyroid hormone receptor-beta (THR-β). Resmetirom produced 83.8% of the maximum response compared to triiodothyronine (T3), with an EC50 of 0.21 µM in an in vitro functional assay for THR-β activation. The same functional assay for thyroid hormone receptor-alpha (THR-α) agonism showed 48.6% efficacy for Resmetirom relative to T3, with an EC50 of 3.74 µM. THR-β is the major form of THR in the liver, and stimulation of THR-β in the liver reduces intrahepatic triglycerides, whereas actions of thyroid hormone outside the liver, including in heart and bone, are largely mediated through THR-α.
Indication
Resmetirom is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) .
Directions for Use
1. Take one tablet orally with a full glass of water.
2. Follow the dosage instructions provided by your healthcare provider.
3. Do not crush or chew the tablet.
4. Store the medication at room temperature away from moisture and heat.
Precautions
- Consult with a healthcare professional before starting this medication.
- Inform your doctor of any allergies or medical conditions before use.
- Do not exceed the recommended dosage to avoid potential side effects.
- Keep out of reach of children.
Storage Instructions
Store Resmeta 100mg Tabs 14s in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture and heat.
Manufacturer Information
Helix is a reputable pharmaceutical company known for producing high-quality medications to improve health and well-being. With a commitment to excellence and innovation, Helix continues to develop safe and effective products for consumers worldwide.
| Manufacturer | Helix |
|---|---|
| Ingredients | Resmetirom |
| Size | Pack of 1 Tablets |
| Prescription Required | No |
| Form | Tablets |
| PrePayment | No |
| FreeShipment | No |
| Top Selling | No |
| Hot Deals | No |
| Sponsored | No |
| Medicated | No |